Invention Grant
- Patent Title: Multiplexed nucleic acid detection kit for human papilloma virus (HPV) typing, and detection method
-
Application No.: US18512036Application Date: 2023-11-17
-
Publication No.: US12168807B2Publication Date: 2024-12-17
- Inventor: Ying Li , Zhichen Xu , Yunhuang Yang , Tao Li
- Applicant: INNOVATION ACADEMY FOR PRECISION MEASUREMENT SCIENCE AND TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
- Applicant Address: CN Wuhan
- Assignee: INNOVATION ACADEMY FOR PRECISION MEASUREMENT SCIENCE AND TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
- Current Assignee: INNOVATION ACADEMY FOR PRECISION MEASUREMENT SCIENCE AND TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
- Current Assignee Address: CN Wuhan
- Agency: True Shepherd LLC
- Agent Andrew C. Cheng
- Priority: CN202111472349.1 20211203
- Main IPC: C12Q1/70
- IPC: C12Q1/70

Abstract:
A multi-target nucleic acid detection kit for human papillomavirus (HPV) typing includes a recombinase polymerase amplification (RPA) primer set, an enzyme and a buffer system for Cas12a-crRNA, and a reporter molecule that displays a signal. In the detection method, a multi-channel microfluidic chip is used as a carrier, and RPA primers are designed for corresponding regions of different HPV subtypes to allow isothermal amplification. A crRNA set is designed for amplicons of different subtypes. The crRNA recognizes an HPV target in a sample, and then activates the CRISPR-Cas12a and cuts a reporter group to release a signal, thereby achieving accurate detection on HPV subtypes. The detection method shows a high sensitivity, a low cost, and easy operations, and is expected to be widely used in the screening of HPV infection.
Public/Granted literature
- US20240150856A1 MULTIPLEXED NUCLEIC ACID DETECTION KIT FOR HUMAN PAPILLOMAVIRUS (HPV) TYPING, AND DETECTION METHOD Public/Granted day:2024-05-09
Information query